Tytuł artykułu
Wybrane pełne teksty z tego czasopisma
Identyfikatory
Warianty tytułu
Języki publikacji
Abstrakty
A hollow-fiber liquid-phase microextraction (HF-LPME), followed by high-performance liquid chromatography–ultraviolet (HPLC–UV) method for the trace determination of carvedilol (β-blocker) in biological fluids, has been described. The separation was achieved using Inertsil ODS-3 C18 (250 mm × 4.6 mm, 3 μm) column with a mobile phase composition of 10 mM phosphate buffer (pH 4.0)–acetonitrile (50:50, v/v) at a flow rate of 1.0 mL/min, under isocratic elution. Several parameters (i.e., type of organic solvent, donor phase pH, concentration of acceptor phase (AP), stirring rate, extraction time, and salt addition) that affect the extraction efficiency were investigated. The optimum HF-LPME conditions were as follows: dihexyl ether as an organic solvent; donor phase pH, 10.7; 0.1 M HCl (AP); 1100-rpm stirring rate; 60-min extraction time; and no salt addition. These parameters have been confirmed using design of experiments. Under these conditions, an enrichment factor of 273-fold was achieved. Good linearity and correlation coefficient were obtained over the range 5–1000 ng/mL (r2 = 0.9994). Limits of detection and quantitation were 1.2 and 3.7 ng/mL, respectively. The relative standard deviation at 3 different concentration levels (5, 500, and 1000 ng/mL) were less than 13.2%. Recoveries for spiked urine and plasma were in the range 80.7–114%. The proposed method is simple, sensitive, and suitable for the determination of carvedilol in biological fluids.
Czasopismo
Rocznik
Tom
Strony
149--155
Opis fizyczny
Bibliogr. 37 poz., rys.
Twórcy
Bibliografia
- [1] Wishart, D. S.; Feunang, Y. D.; Guo, A. C.; Lo, E. J.; Marcu, A.; Grant, J. R.; Sajed, T.; Johnson, D.; Li, C.; Sayeeda, Z.; Assempour, N.; Iynkkaran, I.; Liu, Y.; Maciejewski, A.; Gale, N.; Wilson, A.; Chin, L.; Cummings, R.; Le, D.; Pon, A.; Knox, C.; Wilson, M. Nucleic Acids Res. 2018, 46, D1074.
- [2] Furlong, M. T.; He, B.; Mylott, W.; Zhao, S.; Mariannino, T.; Shen, J.; Stouffer, B. J. Pharm. Biomed. Anal. 2012, 70, 574.
- [3] Talebpour, Z.; Taraji, M.; Adib, N. J. Chromatogr. A 2012, 1236, 1.
- [4] Feuerstein, G. Z.; Bril, A.; Ruffolo Jr, R. R.; Am. J. Cardio. 1997, 80, 41L.
- [5] Möllendorff, E. V.; Reiff, K.; Neugebauer . J. Clin. Pharmacol. 1987, 33, 511.
- [6] Gehr, T. W. B.; Tenero, D. M.; Boyle, D. A.; Qian, Y.; Sica, D. A.; Shusterman, N.H. Eur. J. Clin. Pharmacol. 1999, 55, 269.
- [7] Phuong, N. T.; Lee, B. J.; Choi, J. K.; Kang, J. S.; Kwon, K. Arch. Pharm. Res. 2004, 27, 973.
- [8] Shrivastav, P. S.; Buha, S. M.; Sanyal, M. Bioanalysis 2010, 2, 263.
- [9] Soltani, S.; Ramezani, A. M.; Soltani, N.; Jouyban, A. Bioanalysis 2012, 4, 2805.
- [10] Belal, T. S.; Shaalan, R. A.; El Yazbi, F. A.; Elonsy, S. M. Chromatographia 2013, 76, 1707.
- [11] Stojanović, J.; Marinković, V.; Vladimirov, S.; Veličković, D.; Sibinović, P. Chromatographia 2005, 62, 539.
- [12] Lamprecht, G.; Stoschitzky, K. Chromatographia 2004, 59, 551.
- [13] Ptáček, P.; Macek, J.; Klíma, J. J. Chromatogr. B 2003, 789, 405.
- [14] Zarghi, A.; Foroutan, S. M.; Shafaati, A.; Khoddam, A. J. Pharm. Biomed. Anal. 2007, 44, 250.
- [15] Yamsani, V. V.; Gannu, R.; Yamsani, M. R.; Veerabrahma, K. J. Chromatogr. Sci. 2010, 48, 348.
- [16] Behn, F.; Läer, S.; Mir, T. S.; Scholz, H. Chromatographia 2001, 53, 641.
- [17] Butnariu, A.; Popa, D.-S.; Vlase, L.; Andreica, M.; Muntean, D.; Leucuţa, S. Rev. Romana Med. Lab. 2009, 15, 7.
- [18] Carmo Borges, N. C.; Mendes, G. D.; Oliveira Silva, D.; Rezende, V. M.; Barrientos-Astigarraga, R. E.; Nucci, G. D. J. Chromatogr. B 2005, 822, 253.
- [19] Jeong, D. W.; Kim, Y. H.; Ji, H. Y.; Youn, Y. S.; Lee, K. C.; Lee, H. S. J. Pharm. Biomed. Anal. 2007, 44, 547.
- [20] Yilmaz, B.; Arslan, S. J. Chromatogr. Sci. 2011, 49, 35.
- [21] Myung, S.-W.; Jo, C.-H. J. Chromatogr. B 2005, 822, 70.
- [22] Al Arfaj, N.; Abdine, H. H.; SuItan, M. A. Int. J. Biomed. Sci. 2007, 3, 132.
- [23] Pires, C. K.; Marques, K. L.; Santos, J. L. M.; Lapa, R. A. S.; Lima, J. L. F. C.; Zagatto, E. A. G. Talanta 2005, 68, 239.
- [24] Silva, R. A.; Wang, C. C.; Fernández, L. P.; Masi, A. N. Talanta 2008, 76, 166.
- [25] Xiao, Y.; Wang, H. Y.; Han, J. Spectrochim. Acta A 2005, 61, 567.
- [26] Xu, L. X.; Hui, N.; Ma, L. Y.; Wang, H. Y. Spectrochim. Acta A 2005, 61, 855.
- [27] Zamani-Kalajahi, M.; Fazeli-Bakhtiyari, R.; Amiri, M.; Golmohammadi, A.; Afrasiabi, A.; Khoubnasabjafari, M.; Jouyban, A. Bioanalysis 2013, 5, 437.
- [28] Baranowska, I.; Magiera, S.; Baranowski, J. J. Chromatogr. B 2011, 879, 615.
- [29] Larnprecht, G.; Gruber, L.; Stoschitzky, K.; Lindner, W. Chromatographia 2002, 56, S-25.
- [30] Jiang, J.; Tian, L.; Huang, Y.; Yan, Y.; Li, Y. J. Chromatogr. B 2014, 960, 92.
- [31] Clohs, L.; McErlane, K. M. J. Pharm. Biomed. Anal. 2001, 24, 545.
- [32] Zakrzewski-Jakubiak, M.; Denus, S.; Leblanc, M.-H.; White, M.; Turgeon, J. J. Pharm. Biomed. Anal. 2010, 52, 636.
- [33] Xu, L.; Basheer, C.; Lee, H. K. J. Chromatogr. A 2009, 1216, 701.
- [34] Mirzaei, M.; Dinpanah, H. J. Chromatogr. B 2011, 879, 1870.
- [35] Al Azzam, K. M.; Makahleh, A.; Saad, B.; Mansor, S. M. J. Chromatogr. A 2010, 1217, 3654.
- [36] Ben-Hander, G. M.; Makahleh, A.; Saad, B.; Saleh, M. I. J. Chromatogr. B 2013, 941, 123.
- [37] Han, D.; Row, K. H. Microchim. Acta 2012, 176, 1.
Uwagi
PL
Opracowanie rekordu ze środków MNiSW, umowa Nr 461252 w ramach programu "Społeczna odpowiedzialność nauki" - moduł: Popularyzacja nauki i promocja sportu (2020).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-32753183-78a0-495d-b004-1803c887b37c